Microbiome for early cancer prediction before the onset of disease
Ente erogante: Commissione Europea - Horizon Europe
Scadenza
15 settembre 2026
151 giorni rimanenti
Forma
Fondo perduto
Budget totale
Non specificato
Contributo max
Non specificato
Descrizione del bando
Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Healthy people and in particular people at risk will benefit from microbiome tests and programmes that can discover and predict their transition to cancer before the onset of disease.People will have a better understanding of risks and will be enabled to address risks early by following treatments or adapting their lifestyles, including nutrition and other interventions.Physicians will be able to start cancer treatments earlier with a higher success rate.Policy makers and authorities will be enabled to develop and implement advanced and strategic programmes addressing cancer prevention. Scope:This topic will contribute to the achievement of the EU Cancer Mission’s objective to achieve better cancer prevention and early detection. The focus is on the development of validated microbiome tools, an assessment of predispositions, the comparison with other predictive tools and risk modelling approaches.Cancer often develops over several years and progresses silently before symptoms appear. Some cancers are diagnosed at a very late stage, when the disease is nearly incurable. Early and sensitive biomarkers are beneficial for preventive strategies and the survival of patients especially when tests are minimally invasive and simple to perform. The human microbiome is correlated with this process of oncogenesis and tumour progression. The deterioration of the human microbiome towards dysbiosis should be monitored and used as an early predictive biomarker. The potential of the microbiome should be exploited to deliver important contributions to cancer prevention and early detection strategies before the onset of disease especially for high-risk patients.Prevention of cancer through early detection is most efficient in fighting cancer and saving lives. Large microbiome biobanks and registries exist at national
Non capisci questo bando?
L'AI di Bandiora te lo spiega in modo semplice: requisiti, importi, scadenze e a chi è rivolto, tutto chiaro.
Registrati e fatti spiegare il bando dall'AIArea geografica
Tematiche
Requisiti dettagliati
Questo bando è rivolto a 3 tipologie di impresa in 3 settori ATECO nell'area eu.
Scopri con l'AI se questo bando è adatto alla tua azienda
Analisi automatica di compatibilità, requisiti e matching in tempo reale
Prova gratis 7 giorniQuesto bando fa per la tua azienda?
L'AI di Bandiora analizza la compatibilità con la tua azienda in tempo reale e ti assiste nella compilazione della candidatura, passo dopo passo.
Altri bandi che potrebbero interessarti
Support to test EIC innovations for public and private procurers
Commissione Europea
Scadenza: 17 aprile 2026
Accelerating the discovery and development of chemicals and innovative advanced materials through digitalisation and artificial intelligence (IA) (Innovative Advanced Materials for the EU partnership)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Improving availability of secondary raw materials through recycling (IA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Monitoring of secondary raw materials (CSA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026